EGANELISIB

UNII:	FOF5155FMZ
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₀H₂₄N₈O₂
Preferred Substance Name:	EGANELISIB
InChIKey:	XUMALORDVCFWKV-IBGZPJMESA-N
GSRS Full Record:	FOF5155FMZ i

1693758-51-8
(S)-2-AMINO-N-(1-(8-((1-METHYL-1H-PYRAZOL-4-YL)ETHYNYL)-1-OXO-2-PHENYL-1,2- DIHYDROISOQUINOLIN-3-YL)ETHYL)PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBOXAMIDE
2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
2-amino-N-[(1S)-1-{8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl- 1,2-dihydroisoquinolin-3-yl}ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
EGANELISIB [USAN]
Eganelisib [WHO-DD]
IPI-549
PI3K-GAMMA INHIBITOR IPI-549
PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBOXAMIDE, 2-AMINO-N-((1S)-1-(1,2-DIHYDRO-8-(2-(1-METHYL-1H-PYRAZOL-4-YL)ETHYNYL)-1-OXO-2-PHENYL-3-ISOQUINOLINYL)ETHYL)-
eganelisib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

EGANELISIB

Synonyms and Mappings

Resources